The Value of BCG and TNF in Autoimmunity
- Denise Faustman, Director of the Immunobiology Laboratory, Massachusetts General Hospital (MGH) and Associate Professor of Medicine, Harvard Medical School, USA
Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity.
AudienceThis book is intended for clinical researchers and scientists working in the fields of autoimmunity and/or immunology.
- Published: March 2014
- Imprint: ACADEMIC PRESS
- ISBN: 978-0-12-799964-7
Table of Contents
- Mycobacteria, Immunoregulation, and Autoimmunity
- Prevention of Type 1 Diabetes and Its Recurrence by Immunotherapy with Mycobacterial Adjuvants
- Proteasome Defects and Cytokine Signaling in SjÃ¶grenâs Syndrome
- The Protective Effect of the BCG Vaccine on the Development of Type 1 Diabetes in Humans
- Effects of the Bacillus Calmette-GuÃ©rin (BCG) Vaccine in the Demyelinating Disease of the Central Nervous System
- TNF, BCG, and the Proteasome in Autoimmunity: An Overview of the Pathways & Results of a Phase I Study in Type 1 Diabetes
- Why Test BCG in SjÃ¶grenâs Syndrome?
- Celiac Disease as a Model Disorder for Testing Novel Autoimmune Therapeutics
- Delivering Solutions and Clinical Benefits for Diseases with Small and Intermediate-Size Patient Populations